Apex Energetics

NeuroFlam (K-46)

D
N+ Score64
Longevity & NAD+Serving: 1 Vegetarian Capsule(s)Type: Other Combinations

NeuroFlam (K-46) is a Longevity & NAD+ category supplement featuring a blend of seven botanical ingredients, including Catechins (100mg), Curcuminoids (100mg), and Resveratrol (50mg). This product has an N+ Score of 64, earning it a 'D' grade, indicating an average tier product according to our analysis. While the label transparency is 100%, none of the listed ingredients are present at dosages commonly recognized as clinical, suggesting they may be underdosed for their intended effects. The product's ingredient adequacy and formula completeness scores are 50% and 25% respectively, highlighting potential areas for improvement. This supplement might be considered by individuals exploring general longevity support with a diverse botanical complex.

About This Product

NeuroFlam (K-46) by Apex Energetics is a longevity & nad+ supplement containing 7 active ingredients. It has earned an N+ Score of 64/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (7 ingredients)

IngredientAmountDose Adequacy
Rutin75.000 mgN/A
Curcuminoids100.000 mgN/A
Resveratrol50.000 mgN/A
Luteolin20.000 mgN/A
Apigenin30.000 mgN/A
Catechins100.000 mgN/A
Baicalin60.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.